Showing results (151-160 of 186) with videos related to
Sort By:
Pageof 19
The Lancet Regional Health. Western Pacific|May 29, 2024
Zuberitamab, an innovative anti-CD20 monoclonal antibody, for patients with primary immune thrombocytopenia in China: a randomized, double-blind, placebo-controlled, phase 2 studyMin Xu, Jinhui Shu, Shenxian Qian, et al.Bioorganic Chemistry|October 27, 2023
Design, synthesis and triglyceride-lowering activity of tricyclic matrine derivatives for the intervention of non-alcoholic fatty liver diseaseJing-Yang Zhu, Mei Tang, Hu Li, et al.Journal for Immunotherapy of Cancer|June 15, 2025
Co-expression of IL-15 and CCL21 strengthens CAR-NK cells to eliminate tumors in concert with T cells and equips them with PI3K/AKT/mTOR signal signatureXindi Wang, Wenjing Luo, Zhaozhao Chen, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 16, 2021
FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m<sup>6</sup>A-YTHDF2-dependent mannerAoshuang Xu, Jiasi Zhang, Liping Zuo, et al.Signal Transduction and Targeted Therapy|September 23, 2021
SARS-CoV-2 infection causes immunodeficiency in recovered patients by downregulating CD19 expression in B cells via enhancing B-cell metabolismYukai Jing, Li Luo, Ying Chen, et al.Journal of Hematology & Oncology|April 9, 2026
Efficacy and safety of hetrombopag, a novel thrombopoietin receptor agonist, in children and adolescents with immune thrombocytopenia: results from a randomized, multicenter, placebo-controlled phase 3 trialRunhui Wu, Ju Gao, Yufeng Liu, et al.American Journal of Hematology|July 20, 2019
Anti-CD19 chimeric antigen receptor-modified T-cell therapy bridging to allogeneic hematopoietic stem cell transplantation for relapsed/refractory B-cell acute lymphoblastic leukemia: An open-label pragmatic clinical trialHuiwen Jiang, Chenggong Li, Ping Yin, et al.Proceedings of the National Academy of Sciences of the United States of America|July 27, 2022
Transcription factor EB coordinates environmental cues to regulate T regulatory cells' mitochondrial fitness and functionMinghui Xia, Cai Zhang, Yufei Chen, et al.Theranostics|August 1, 2022
Inhibition of acylglycerol kinase sensitizes DLBCL to venetoclax via upregulation of FOXO1-mediated BCL-2 expressionNa Ning, Si Zhang, Qi Wu, et al.Journal of Hematology & Oncology|January 21, 2023
Novel CD19-specific γ/δ TCR-T cells in relapsed or refractory diffuse large B-cell lymphomaChenggong Li, Fen Zhou, Jing Wang, et al.Pageof 19